 


Monday


May 23, 1994





Part II



Department of Health and Human Services





Food and Drug Administration





21 CFR Parts 173 and 573
Secondary Direct Food Additives Permitted in Food for Human Consumption; Food Additives Permitted in Feed and Drinking
Water of Animals; Aminoglycoside 3
&rsquo;-Phosphotransferase II; Final Rule









Federal Register

/Vol. 59, No. 98/Monday, May 23, 1994/Rules and Regulations




<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES </USDEPT>





<USBUREAU>Food and Drug Administration</USBUREAU>

21 CFR Parts 173 and 573




<RINDOCK>[Docket No. 93F0232]</RINDOCK>



Secondary Direct Food Additives Permitted in Food for Human Consumption; Food Additives Permitted in Feed and Drinking
Water of Animals; Aminoglycoside 3
&rsquo;-Phosphotransferase II



<AGENCY>
AGENCY:

 Food and Drug Administration, HHS.





</AGENCY>
<ACTION>
ACTION:

 Final rule.






</ACTION>
<SUMMARY>
SUMMARY:

 The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of aminoglycoside
3
&rsquo;-phosphotransferase II (APH(3
&rsquo;)II) as a processing aid in the development of new varieties of tomato, oilseed rape, and cotton. APH(3
&rsquo;)II is a protein encoded by the kanamycin resistance (

kan

r

) gene. This action is in response to a petition filed by Calgene, Inc.





</SUMMARY>
<DATE>
DATES:

 Effective May 23, 1994; written objections and requests for a hearing by June 22, 1994.





</DATE>
<ADDRESS>
ADDRESSES:

 Submit written objections to the Dockets Management Branch (HFA305), Food and Drug Administration, rm. 123,
12420 Parklawn Dr., Rockville, MD 20857.





</ADDRESS>
<FURTHER>
FOR FURTHER INFORMATION CONTACT:

 Nega Beru, Center for Food Safety and Applied Nutrition (HFS206), Food and Drug Administration, 200 C St.,
SW., Washington, DC 20204, 2022549523.



</FURTHER>
<SUPPLEM>
SUPPLEMENTARY INFORMATION:

 



Table of Contents



I. Introduction



A. Regulatory History

B. Scope of the Regulation

C. Determination of Safety



II. Use of the 

kan

r

 Gene as a Selectable Marker in Transgenic Plants



A. Background

B. Need for a Selectable Marker

C. Identity of the Additive

D. Use and Intended Technical Effects



III. Safety Evaluation



A. APH(3
&rsquo;)II

1. Direct effects of ingestion

2. Effects on the therapeutic efficacy of orally administered antibiotics

a. APH(3
&rsquo;)II in human foods

b. APH(3
&rsquo;)II in animal feed

</SUPPLEM>

